Shares of bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report) were down 10.8% during trading on Friday . The stock traded as low as $0.33 and last traded at $0.33. Approximately 100 shares changed hands during mid-day trading, a decline of 99% from the average daily volume of 9,167 shares. The stock had previously closed at $0.37.
bioAffinity Technologies Stock Performance
The company has a 50-day moving average of $0.33 and a 200-day moving average of $0.22.
About bioAffinity Technologies
bioAffinity Technologies, Inc is a clinical-stage medical device company developing an extracorporeal immunoadsorption platform intended to treat Gram-negative sepsis and other severe inflammatory conditions. The company’s technology employs specialized sorbent cartridges designed to selectively bind and remove circulating endotoxins and inflammatory mediators from the bloodstream, with the goal of supporting critical care interventions and improving patient outcomes.
In preclinical studies, bioAffinity’s hemoperfusion devices have demonstrated the ability to capture lipopolysaccharides released by Gram-negative bacteria, leading to reductions in pro-inflammatory cytokines and enhanced survival rates in animal models.
See Also
- Five stocks we like better than bioAffinity Technologies
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Do you know what Amazon is planning for January 1?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
